Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Today, 9:00 AMvVARDIS priced its IPO at $18 per share, selling 9.72 million shares ahead of its NYSE listing.
Index
-
Market Cap
-
Enterprise Value
-
Income
-52.24M
Sales
-
Book/sh
-5.72
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
137
IPO
Nov 13, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
0.70
Current Ratio
0.92
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / No
EPS (ttm)
-2.28
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
24.73%
Sales Q/Q
214.24%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-
SMA50
-
SMA200
-
Trades
Shs Outstand
20.51M
Shs Float
-
52W High
- -
52W Low
- -
Volatility
- -
ATR (14)
-
RSI (14)
-
Beta
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
Perf YTD
-
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
18.00
Price
-
Change %
-
vVARDIS Holding AG is a Swiss dental company that specializes in innovative, biomimetic, and non-invasive dental care products designed to treat early-stage tooth decay without drilling or needles. The company is based in Baar, Switzerland, and has subsidiaries in Switzerland. Its flagship product, Curodont Repair Fluoride Plus, uses guided hydroxyapatite generation technology to remineralize enamel and restore lost minerals in a quick, painless procedure typically completed within a single dental appointment. The company also offers oral care products enriched with hydroxyapatite for daily enamel repair and sensitivity relief, and supports dental professionals with educational resources such as e-learning, webinars, clinical literature, and a clinic locator. The company was founded by Golnar Abivardi-Signer, Haleh Abivardi-Bronner.